Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Related Articles
-
2024 Toyota Tacoma Hybrid Priced From $47,795, Tops Out At $65,395
Across the lineup, the hybrid i-Force Max powertrain adds $3,700 to the price of the Toyota Tacoma
-
High-priced drugs and little evidence is a 'toxic combination' - SWI swissinfo.ch
As the global debate intensifies over whether multi-million-dollar drugs are worth the money, big pharma needs to improve transparency over...
-
Evercore ISI Boosts Cardinal Health (NYSE:CAH) Price Target to $115.00
Cardinal Health (NYSE:CAH – Free Report) had its price target upped by Evercore ISI from $110.00 to $115.00 in a research note published on Friday, Benzinga reports. They currently have an in-line rating on the stock. Several other analysts also recently weighed in on the company. SVB Leerink started coverage on Cardinal Health in a […]